---
figid: PMC5445378__13046_2017_541_Fig2_HTML
figlink: /pmc/articles/PMC5445378/figure/Fig2/
number: Fig. 2
caption: 'E5 immune evasion mechanisms. E5 induces COX-2 expression through: i) the
  activation of the epidermal growth factor receptor (EGF-R) signalling pathway and
  the interaction with the nuclear factor 1 (NF-1), which results in the induction
  of ii) AP-1 and iii) NF-κB transcription, which has the strongest effect on COX-2
  transcription. E5 upregulation of EGF-R expression also leads to an increase of
  the vascular endothelial growth factor (VEGF), through COX-2 []. Following this,
  COX-2 and EP4 stimulate PGE2 signalling pathway through a feedback mechanism involving
  increased levels of cAMP, PKA and CREB (cyclic adenosine monophosphate response
  element binding protein), binding to the EP4 promoter []. This leads to a rise in
  the expression of this receptor [, ], which is associated with breast and colon
  carcinogenesis [, ]. Moreover, E5 impairs MHC I [] and II [] surface cell expression'
pmcid: PMC5445378
papertitle: 'hrHPV E5 oncoprotein: immune evasion and related immunotherapies.'
reftext: Antonio Carlos de Freitas, et al. J Exp Clin Cancer Res. 2017;36:71.
pmc_ranked_result_index: '40609'
pathway_score: 0.9681916
filename: 13046_2017_541_Fig2_HTML.jpg
figtitle: E5 immune evasion mechanisms
year: '2017'
organisms: Homo sapiens
ndex: 982a23e8-deca-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5445378__13046_2017_541_Fig2_HTML.html
  '@type': Dataset
  description: 'E5 immune evasion mechanisms. E5 induces COX-2 expression through:
    i) the activation of the epidermal growth factor receptor (EGF-R) signalling pathway
    and the interaction with the nuclear factor 1 (NF-1), which results in the induction
    of ii) AP-1 and iii) NF-κB transcription, which has the strongest effect on COX-2
    transcription. E5 upregulation of EGF-R expression also leads to an increase of
    the vascular endothelial growth factor (VEGF), through COX-2 []. Following this,
    COX-2 and EP4 stimulate PGE2 signalling pathway through a feedback mechanism involving
    increased levels of cAMP, PKA and CREB (cyclic adenosine monophosphate response
    element binding protein), binding to the EP4 promoter []. This leads to a rise
    in the expression of this receptor [, ], which is associated with breast and colon
    carcinogenesis [, ]. Moreover, E5 impairs MHC I [] and II [] surface cell expression'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUNB
  - FOSL2
  - JUN
  - JUND
  - EGFR
  - PTGER4
  - CREB3L1
  - FOSL1
  - FOSB
  - FOS
  - CREB3L3
  - CREB5
  - BAX
  - CREB3
  - CREM
  - APCS
  - ATF1
  - VEGFC
  - CREB3L2
  - CREB1
  - CREB3L4
  - PRKAR2A
  - PRKAR2B
  - PRKACB
  - VEGFD
  - VEGFA
  - VEGFB
  - PRKAR1B
  - ATF2
  - PRKACA
  - PRKACG
  - PGF
  - PRKAR1A
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: EGF-R
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: APCS
  symbol: APCS
  source: hgnc_symbol
  hgnc_symbol: APCS
  entrez: '325'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
chemicals: []
diseases: []
---
